News
News
- ObsEva Provides Business Outlook for 2021
02/10/2021 / 07:00 - GlobeNewswire - Sanofi, Merck KGaA, Darmstadt, Germany, and More Than 500 Sites Join Inato in Making Clinical Research More Inclusive and Efficient
01/26/2021 / 14:00 - GlobeNewswire - GCP Announces Additional Leadership Changes
01/19/2021 / 12:15 - GlobeNewswire - Philips and Merck partner to advance personalized fertility treatment
01/14/2021 / 10:00 - GlobeNewswire - TRHC’s DoseMeRx® Partners with Physiomics to Provide Precision Dosing for Oncology Medications
12/17/2020 / 15:30 - GlobeNewswire - Immutep Operational Update
12/15/2020 / 14:00 - GlobeNewswire - reMYND commences first-in-human trial of ReS19-T Alzheimer’s program
12/03/2020 / 13:00 - GlobeNewswire - ObsEva SA to present at The International Society of Gynecological Endocrinology 19th World Congress – virtual edition, December 2-5, 2020
12/01/2020 / 07:00 - GlobeNewswire - MediciNova Announces Initiation of Master Virus Seed Stock Production for its Intranasal COVID-19 Vaccine using BC-PIV Vector Technology
11/24/2020 / 12:30 - GlobeNewswire - ObsEva SA Reports Positive Topline Results of the PROLONG Proof-of-Concept Trial of Ebopiprant (OBE022) for Treatment of Preterm Labor
11/16/2020 / 07:00 - GlobeNewswire
Real-time